Abeona Therapeutics (ABEO) Interest & Investment Income (2011 - 2022)
Abeona Therapeutics (ABEO) posted quarterly Interest & Investment Income of $30000.0 for Q2 2022, up 275.0% year-over-year from $8000.0 in Q2 2021, and up 275.0% quarter-over-quarter from $8000.0 in Q2 2021.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Interest & Investment Income (2011 - 2022) Analysis & Trends
Abeona Therapeutics' Interest & Investment Income history runs 11 years deep, the most recent figure standing at $30000.0 for Q2 2022.
- In Q2 2022, Interest & Investment Income rose 275.0% year-over-year to $30000.0; the TTM figure through Jun 2022 stood at $589000.0 (down 46.06% YoY), while the FY2018 annual figure was $1.5 million, up 186.86% from the prior year.
- Interest & Investment Income for Q2 2022 stood at $30000.0, up from $8000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $533000.0 in Q4 2018, with the low at $8000.0 in Q2 2021.
- The 4-year median for Interest & Investment Income is $236500.0 (2018), against an average of $261875.0.
- The sharpest annual moves came in 2018 and 2019: Interest & Investment Income jumped 2280.95% in 2018, then plunged 83.6% in 2019.
- Abeona Therapeutics' Interest & Investment Income stood at $533000.0 in 2018, then slumped by 90.24% to $52000.0 in 2019, then slumped by 84.62% to $8000.0 in 2021, then surged by 275.0% to $30000.0 in 2022.
- Business Quant data shows ABEO's Interest & Investment Income at $30000.0 in Q2 2022, $8000.0 in Q2 2021, and $52000.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 30,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Jun 30, 2019 | 52,000.00 |
| Mar 31, 2019 | 499,000.00 |
| Dec 31, 2018 | 533,000.00 |
| Sep 30, 2018 | 500,000.00 |
| Jun 30, 2018 | 317,000.00 |
| Mar 31, 2018 | 156,000.00 |
| Dec 31, 2017 | 301,000.00 |
| Sep 30, 2017 | 21,000.00 |
| Jun 30, 2017 | 164,000.00 |
| Mar 31, 2017 | 39,000.00 |
| Dec 31, 2016 | -1.17 Mn |
| Sep 30, 2016 | 2.55 Mn |
| Jun 30, 2016 | 13,000.00 |
| Mar 31, 2016 | 618,000.00 |
| Dec 31, 2015 | 3.92 Mn |
| Sep 30, 2015 | 92,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Mar 31, 2015 | 3,000.00 |